Evanthia Bernitsas - JoVE Visualize

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

Diagnostics (Basel, Switzerland)|January 21, 2022

A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial DesignEwart Mark Haacke, Evanthia Bernitsas, Karthik Subramanian, et al.

Multiple Sclerosis and Related Disorders|June 25, 2023

Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.

Journal of Neurology|November 15, 2022

Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectivesPenny Pennington, Bianca Weinstock-Guttman, Channa Kolb, et al.

JAMA Neurology|February 18, 2020

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.

Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

Diagnostics (Basel, Switzerland)|January 21, 2022

A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial DesignEwart Mark Haacke, Evanthia Bernitsas, Karthik Subramanian, et al.

Multiple Sclerosis and Related Disorders|June 25, 2023

Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.

Journal of Neurology|November 15, 2022

Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectivesPenny Pennington, Bianca Weinstock-Guttman, Channa Kolb, et al.

JAMA Neurology|February 18, 2020

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.

Pageof 6